United States Renews its Commitment to Combat HIV/AIDS in Tanzania

The Chargé d’Affaires of the United States Embassy, Dr. Inmi Patterson meets the Deputy Minister for Health, Dr. Faustine Ndugulile during a visit at the Mnazi Mmoja Hospital in Dar es Salaam
The Chargé d’Affaires of the United States Embassy, Dr. Inmi Patterson meets the Deputy Minister for Health, Dr. Faustine Ndugulile during a visit at the Mnazi Mmoja Hospital in Dar es Salaam

Dar es Salaam, TANZANIA. On Friday, May 4, Chargé d’Affaires of the Embassy of the United States of America Inmi Patterson announced during a visit to Mnazi Mmoja Hospital with Tanzanian Deputy Minister of Health Dr. Faustine Ndugulile, that the United States Government, through the President’s Emergency Plan for AIDS Relief (PEPFAR), has committed an additional $512 million (approximately 1.17 trillion TZS) to combat the HIV/AIDS epidemic in Tanzania.  Designed in partnership with the Government of Tanzania, PEPFAR’s Country Operational Plan seeks to bring the HIV/AIDS epidemic under control by September 2019.  The United States Government, through PEPFAR, has spent more than $4.5 billion (approximately 10.26 trillion TZS) to stop the transmission of HIV/AIDS in Tanzania since 2004.

“I am proud to announce today that through PEPFAR, the U.S. Government will spend an additional $512 million (1.17 trillion TZS) to improve HIV prevention, testing, and treatment in Tanzania through September 2019. The results from the Tanzania HIV Impact Survey in December 2017 showed us that Tanzania has fallen behind other countries in the region. Specifically, only about half of all people with HIV in Tanzania have been tested and know that they have HIV.  Tanzania must get back on track, and this will require far greater public awareness and people to get tested, urgent efforts to adopt new policies, and even quicker implementation of those policies.”

The Chargé d’Affaires of the United States Embassy, Dr. Inmi Patterson and the Deputy Minister for Health, Dr. Faustine Ndugulile address the media at the Mnazi Mmoja Hospital in Dar es Salaam
The Chargé d’Affaires of the United States Embassy, Dr. Inmi Patterson and the Deputy Minister for Health, Dr. Faustine Ndugulile address the media at the Mnazi Mmoja Hospital in Dar es Salaam

PEPFAR encourages everyone, especially men, to talk to a health worker about getting tested for HIV. Anyone who discovers they are HIV-positive can immediately begin treatment. Nearly one million HIV-positive Tanzanians are on lifesaving treatment, and most are living long and healthy lives and have such low levels of the virus that they are virtually unable to pass the virus to others, including sexual partners and their babies.

For more information on PEPFAR in Tanzania please visit the U.S. Embassy’s website at https://tz.usembassy.gov/our-relationship/pepfar/.

To request more information about this statement, please call the U.S. Embassy Dar es Salaam Press Office at Tel: +255 22 229-4000 or email: DPO@state.gov.

Background Information: U.S. President’s Emergency Plan for AIDS Relief (PEPFAR)in Tanzania

Program background and statistics on the impact of the program:

  • In fiscal year 2017 alone, PEPFAR provided HIV testing for 9 million Tanzanians.
  • PEPFAR supports 950,000 Tanzanians on lifesaving medication (antiretroviral treatment); Goal: 1 million Tanzanians on lifesaving treatment by end of 2018
  • In fiscal year 2017, PEPFAR provided lifesaving medication to 56,000 pregnant women to prevent mother-to-child transmission of HIV

Since PEPFAR began in 2003:

  • AIDS-related deaths decreased 70%, from 110,000 in 2003 to 33,000 in 2016
  • Annual new infections have dropped by almost half from 100,000 in 2003 to 55,000 in 2016
  • HIV programs in Tanzania prevented 1.1 million new infections and 690,000 deaths


PEPFAR’s 15-year commitment to Tanzanians reflects the enduring value of our relationship with 
the Tanzanian people:

  • Through PEPFAR, the USG has spent about 9 trillion TZS (4 billion USD)
  • Funding for 2018 is over 1 trillion TZS (512 million USD)
  • PEPFAR currently provides 73.8% of funding for HIV programs in Tanzania
  • PEPFAR provides 68.0% of funding for ARVs and 81.3% of funding for rapid test kits